Figure 1 Percentage of families with CDKN2A mutations by number of patients with cutaneous malignant melanoma per family (no. of CMM/family: 3, 4, 5 and ⩾6) for each of the four groups (total, North America, Australia and Europe). p Values are shown for each of the four groups.